Incubation of rat liver cytosolic or microsomal fractions with chromium(VI) led to a dramatic decrease in chromium(VI) mutagenidty, as determined by the Ames Salmonella assay using the TA100 tester strain. The cytosol-dependent decrease in chromium(VI) mutagenidty was found to be counteracted in the presence of dicumarol, an inhibitor of the cytosolic enzyme NAD(P)H:quinone oxidoreductase (DT-diaphorase). In order to determine whether DT-diaphorase is a significant factor in enzymatic reduction of chromium(VI) in rat liver tissue, cytosolk and microsomal fractions were analyzed for NAD(P)H-dependent chromhim(VI) reductase activity leading to chromium(V) formation by using electron paramagnetic resonance (EPR) spectroscopy. Reaction of chromium(VI) with NADH or NADPH in the presence of either cytosolic or microsomal fractions led to the formation of stable chromium(V)-NAD(P)H complexes. When glucose 6-phosphate (G6P) was present in the reaction as part of a N ADPHgenerating system, stable chromium(V) -G6P complexes were formed in addition to the chromium(V)-NAD(P)H complexes. The chromium(V) complexes had g values of 1.980-1.982 and superhyperfine splitting constants of 0.8 -0.9 characteristic of Ws(diol)oxochromium(V) complexes. Inhibition of 90% of the cytosolic DT-diaphorase activity by dkumarol led to only partial (20-22%) inhibition of chromium(V) formation. Visible and EPR spectroscopic studies showed that purified DT-diaphorase had no detectable chromium(VI) reductase activity and did not catalyze formation of chromium(V). Inhibition of 69% of microsomal aryl hydrocarbon hydroxylase activity by ketoconazole led to partial (10%) inhibition of chromium(V) formation. These results indicate that intracellular NAD(P)H-dependent enzymatic reduction of chromium(VI) in rat liver cannot be attributed to the activity of any one enzyme in the cytosolic or mkrosomal fractions. DT-diaphorase appears to play an
Introduction
The importance of reductive cellular metabolism to the carcinogenicity and genotoxicity of chromium(VI) compounds is well-documented in the literature (1). In terms of chromium(VI) reduction by non-enzymatic low mol. wt cellular components, ascorbate has been shown to be the principal reductant of chromium(VT) in rat liver and kidney ultrafiltrates, whereas glutathione is a minor reductant (2) . Cellular enzymes which have been shown to reduce chromium(VI) in vitro include microsomal cytochrome P450 (3) (4) (5) , cytosolic aldehyde oxidase (6) , glutathione reductase (7, 8 ) and NAD(P)H:quinone oxidoreductase (DT-diaphorase*) (9) , and the mitochondrial enzymes NADHrubiquinone oxidoreductase, succinate:ubiquinone oxidoreductase and cytochrome c:oxygen oxidoreductase (10) . Incubation of chromium(VI) with microsomes (11), mitochondria (10, 12) or glutathione reductase (8, 13) has been shown to result in the formation of chromium(V) species.
It has been suggested that the enzyme DT-diaphorase contributes to the cytosolic reduction of cnromium(VT) in vitro (9) . Both purified DT-diaphorase and rat liver cytosolic fractions, which are rich in DT-diaphorase activity, decreased the number of chromium(VI)-induced revertants in the Ames Salmonella mutagenesis assay; however, the number of chromium(VI)-induced revertants was increased in the presence of dicumarol, an inhibitor of DT-diaphorase (14) . The chromium(VI) reductase activity of rat liver cytosolic fractions was inhibited ~ 30-50% by dicumarol (9) . However, incubation of chromium(VT) with purified DT-diaphorase in the presence of NADPH as the electron donor showed no detectable reduction of chromium(VI) (14) . DT-diaphorase normally carries out a two-electron transfer from electron donors, such as NADH and NADPH, to quinones, converting the quinones into the stable hydroquinone form without the generation of intermediate semiquinone and superoxide radical species (15) . Because this reaction does not involve the production of toxic free radical intermediates, the function of DT-diaphorase is believed to be that of protection of cells against the toxicity of quinones and their metabolic precursors such as benzene and benzo [a] pyrene (15) . In the case of chromium(VT) as a potential substrate, a two-electron transfer from DT-diaphorase would reduce chromium(VT) to chromium(IV); however, disproportionation of chromiumQV) could lead to chromium(V) formation. Chromium(V) has been implicated as a DNA-damaging agent (16) (17) (18) (19) (20) (21) and chromium(V) complexes have been shown to be mutagenic in Salmonella typhimurium TA100 (19) .
In this study, electron paramagnetic resonance (EPR) spectroscopy was used to detect possible formation of chromium(V) species upon reduction of chromium(VI) by rat liver cytosolic (S-105) and microsomal fractions under conditions 1159 which were similar to those used in the Salmonella reversion assay for chromium(VI) mutagenicity. Under all conditions, reaction of chromium(VI) with the S-105 or microsomal subcellular fractions in the presence of NAD(P)H resulted in formation of chromium(V) complexes of NADH, NADPH or glucose 6-phosphate (G6P) typical of ft«(diol)oxochromium(V) species (22) (23) (24) , as suggested by their g values and superhyperfine splitting constants. Formation of chromium(V) was only partially inhibited by either dicumarol, an inhibitor of DT-diaphorase, or ketoconazole, an inhibitor of 3-methylcholanthrene (MQ-inducible cytochrome P450 and cytochrome P450 3A enzymes. Incubation of chromium(VI) with purified DT-diaphorase and NADPH led to no detectable formation of chromium(V) over control incubations consisting of chromium(VT) and NADPH alone. These results suggest that chromium(V) is generated from chromium(VI) by multiple intracellular reduction pathways. This study also suggests that the presence of sugars and pyridine nucleotides in the cell complex stabilizes the chromium(V) formed upon metabolic reduction of chromium(VI). , bovine serum albumin (BSA), monobasic (NaH2PO4) and dibasic (Na^PO^) enzyme grade sodium phosphate, [±]-cis-l-acetyl-4-[4-<[2-{2,4-dichlorophenyl)2-(lWirnidazoM-ylmemyl)l,3-dk>xc4an-4-yl]menV>xy)phenyl]pirjeraziiie (ketoconazole), 2,6-dichlorophenolindophenol (DCPIP) and 3,3'-methylene-£>ir(4-hydroxycoumarin) (dicumarol) were purchased from the Sigma Chemical Company, St Louis, MO. G6P and yeast glucose 6-phosphate dehydrogenase (G6PD) were obtained from Boehringer Mannheim Biochemicals, Indianapolis, IN. Aroclor 1254 was a gift from Monsanto Company, St Louis, MO. DT-diaphorase, purified from rat liver as described earlier (25) , was a generous gift from Dr Paul Talalay and Dr Hans Prochaska, Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD. Activities of the purified preparations, assayed using menadione as a substrate (25) , were between 1610 and 1710 IU/mg protein.
Materials and methods

Chemicals
Treatment of rats, preparation of subcellular fractions, mutagenidty assay and enzyme activity assays
Male adult Sprague-Dawley rats ('Morini' strain) were divided into groups of 10 animals each, and were either untreated or treated, 5 days before being killed, with a single i.p. injection (500 mg/kg) of Aroclor 1254, diluted in com oil to a concentration of 200 mg/ml. The rats were killed 5 days after treatment, and liver preparations obtained as described earlier (26) . Four types of liver preparations were studied in chromium(Vr) mutagenicity assays: (i) whole cell homogenates, (ii) S-12 fractions, i.e. the supernatants obtained by centrifuging the cell homogenates twice for 20 min at 12 000 g, (iii) S-105 or cytosolic fractions, i.e. the supernatants obtained by centrifuging the S-12 fractions at 105 000 g for 1 h and, (iv) microsomal fractions, i.e. the pellets resulting from the ccntrifugalion at 105 000 g, washed once and resuspended in a 50 mM Tris-0.1 mM EDTA solution, pH 7.4, supplemented with 20% glycerol (0.5 mg/g of original tissue). Since the aim of this study was to determine the enzymatic metabolism of chromium(Vr) by rat liver cytosolic and microsomal fractions, no special precautions were taken to avoid oxidation of non-enzymatic reductants, such as ascorbate and glutathione, in the preparation of cellular fractions, i.e. buffers were not deaerated nor were they treated with cation exchange resin to remove iron (2) . All the cell preparations were divided into small aliquots and stored at -70°C until use. Their protein content was determined as described by Bradford (27) . DT-diaphorase activity in the fractions was measured by a modification of the method of Ernster et al (28, 29) . The assay system (3.0 ml total volume) in 100 mM phosphate buffer, pH 7.4, 25°C, consisted of 0.2 mM NADH = 340 nra, e = 6.2 X 10^"' cm" 1 ), 0.07% BSA, 40 pM DCPIP (X^, = 610 nm, e =2.1 X lf/M" 1 cm" 1 ; stock solution (1.2 mM) in 0.1 N NaOH, adjusted to pH 10.0) or 40 ^M sodium dichromate (Na 2 Cr 2 O 7 • 2H 2 O, X^, = 372 nm, £ = 4.6 X lCr'M" 1 cm" 1 , pH 7.4) in the presence or absence of either metabolic fractions (S-105 or microsomes) or purified DT-diaphorase (2.8 X 10~5 mg protein, ~ 15 x 10~3 IU/ml). Reactions were monitored by the decrease in the absorbance at either 610 nm (X,^ for DCPIP) or 340 nm Qimn for NADH). When sodium dichromate was used as the electron acceptor, -4% of the absorbance at 340 nm was estimated to arise due to chromate (X^= 372 nm, e^ = 1.35 x lO'M" 1 cm" 1 , pH 7.4) absorption. The dicumarolinhibitable portion of the reaction was determined by subtracting the change in absorbance when dicumarol (10 fiM) was added to the reaction from the change in absorbance in the absence of dicumarol. The net change in absorbance was used to determine DT-diaphorase activity in the metabolic fractions or in the purified enzyme preparations. The DT-diaphorase activity assay described above was also carried out using 1.0 mM chromate as electron acceptor, 4.0 mM NADPH as electron donor and 40 IU/ml purified DT-diaphorase, and the extent of dkumarol-inhibitable chromate reduction was determined by monitoring the decrease in absorbance al 405 nm (e^ = 1.25 x 10 3 M"' cm" 1 , pH 7.4). Glutathione was estimated as the non-protein sulfhydryl assay described by FJlman (30) . Cytochrome P450 levels were measured using the CO difference spectral assay (A^^-A^go; e = 91 X 10 3 M" 1 cm" 1 ) (4) . As a measure of cytochrome P45O activity, the aryl hydrocarbon hydroxylase (AHH) activity assay was performed, as described by Hamilton et al. (31) . Mutagenicity of chromium(VI) (sodium dichromate) in the presence of these metabolic fractions was assayed according to the Ames Salmonella mutagenesis assay using the TA100 tester strain, as described earlier (9, 14) .
Reaction of chromium(VI) and NAD(P)H in the presence of rat liver cytosolic (S-105) or microsomal fractions: EPR spectroscopy at 297 K
The phosphate buffer was treated with AG 50W-X8 cation exchange resin for several hours and filtered before use. All reactions were carried out in a total volume of 500 pi, under conditions that were similar to those of the mutagenicity assays carried out by De Flora et al. (14) . Stock solutions of all reaction components were prepared in 100 mM phosphate buffer, pH 7.4, 24°C, and the rat liver fractions were diluted with the same buffer. Yeast G6PD (1000 U) was dissolved in water (1.0 ml) and stored in 50 pi aliquots at -20°C until use, when the appropriate dilution was made with 100 mM phosphate buffer, pH 7.4, 24°C. Dicumarol was dissolved in 0.1 N NaOH, pH 10.0, as it is poorly soluble at lower pH. Ketoconazole (13. For the EPR spectroscopic studies, reactions typically consisted of 1.0 mM chromium(Vi) (0.5 mM N^GJO^HJO), and 1.0 mg/ml protein (S-105 or microsomal fractions) or 40 IU/mJ purified DT-diaphorase, mixed with 4.0 mM NADPH, 4.0 mM NADH or a NADPH-generating system composed of 5.0 mM G6P, 4.0 mM NADP + , 8.0 mM MgCl 2 , and 33.0 mM KC1. The NADPHgenerating system reached equilibrium in 10 nrin at 24°C, as judged by monitoring the increase in NADPH absorbance at 340 nm (e = 6.2 x 10 3 M" 1 cm" 1 ), and the equilibrium concentration of NADPH at 10 min was determined to be 3.4 ± 0.2 mM. For the microsomal fractions, the NADPH-generating system was supplemented with yeast G6PD (8 IU/ml). Reactions were carried out in 100 mM phosphate buffer, pH 7.4, 24°C. All reactions were initiated by addition of chromiumfvT) to a preincubation mixture (10 min) of the other reactants in the system. In some of the reactions, dicumarol (50 pM) or ketoconazole (50 pM) was present. EPR spectra of chromium(V) species formed during the reaction of chromium(VT) with NADH, NADPH or G6P, were obtained under the following conditions: fl) 5.0 mM chromium(VI) (2.5 mM Na 2 Cr 2 O 7 -2H 2 O) was reacted with 20.0 mM NADH or NADPH, and (ii) 60.0 mM chromium(VI) (30.0 mM Na^Oj^fyO) was reacted with 300 mM G6P in 100 mM phosphate buffer, pH 7.4, 24°C. The reaction with G6P was allowed to proceed for a period of 6 h before analysis by EPR spectroscopy. Aliquots (40 pi) of all reactions were taken in melting point capillaries and EPR spectra recorded at 297 K using a Bruker ESP-300 spectrometer with 100 kHz field modulation, 0.1 G or 1.0 G modulation amplitude, 1.0 x 10 5 or 1.6 x 10 5 receiver gain, 35 G sweep width, 5.12 ms time constant, 2 mW output microwave power and 9.425-9.445 GHz microwave frequency. A Hewlett Packard Model X532B frequency meter was used for calibration, and DPPH (# = 2.0036 ± 0.0003) was used as a reference standard. The intensities of the EPR signals were determined by double-integration analysis of the first derivative spectra, as described earlier (18) . Reactions were scanned for a period of 30 min (21 s/scan). 'I unit (IU) of activity is defined as the amount of enzyme catalyzing the oxidation of 1 jimol NADH (e = 6270 M 'cm ') per minute at pH 7.4, 25°C
IP-
"Not determined. There was no detectable spectral P450 in the S-105 fractions, although a small amount may be present, as determined by ketoconazole-(50 pM) inhibitable AHH activity in the S-105 fractions (0.035 ± 0.01 nmol/min/mg protein). d AHH activity of microsomes in the presence of ketoconazole was 0.102 ± 0.01 nmol/min/mg protein.
Results
Effect ofdicumarol on the ability of rat liver subcellular fractions to revert the mutagenicity of chromium (VI)
The rat liver subcellular fractions were assayed for DT-diaphorase activity. Table I shows that most of the NADH oxidase activity inhibitable by dicumarol (defined as DT-diaphorase activity) was found in the cytosol. The sp. act. in the S-105 cytosolic fraction was almost 40-fold higher than that found in the microsomal fraction (Table I) . On the other hand, MC-inducible, ketoconazole-inhibitable AHH activity was found predominantly in the microsomal fraction (Table I) . Although a small amount of AHH activity was detected in the S-105 fraction, the level of cytochrome P450 enzyme present in the fraction was below the detection limit of the spectrophotometric CO-difference assay (Table I ). As expected, the level of glutathione was uniformly very low in all subcellular fractions (Table I) , since their preparation was carried out aerobically.
Incubation of the subcellular fractions with chromium(VI) led to a decrease in chromium(VI) mutagenicity, as determined by the Ames Salmonella mutagenesis assay. Addition of sodium dichromate (35 /tg, 0.23 mM) to the TA100 Salmonella strain led to an ~ 130-fold increase in the number of revertants when compared to control incubations consisting of the TA100 Salmonella strain alone (Figure 1 ). When the rat liver subcellular fractions were incubated with chromium(VI) in the presence of a NADPH generating system at 37°C for 30 min prior to the mutagenicity assay, a dramatic decrease in the number of chromium(Vl)-induced revertants was observed, and the decrease was proportional to the amount of protein (0.5 mg or 1.0 mg) added to chromium(VT) (Figure 1 ). High sp. act. was detected with both the S-105 and microsomal fractions, which in the case of addition of 1.0 mg protein to chromium(VI) resulted in a decrease in the number of revertants to control levels (Figure 1) . Addition of dicumarol (50 fiM) led to a dramatic recovery of chromium(VT) mutagenicity, i.e. increased number of chromium(VI)-induced revertants in the liver homogenate, S-12 fraction and S-105 fraction (Figure 1 ). In the case of the S-105 fraction, the number of chromium(VT)-induced revertants obtained upon addition ofdicumarol to S-105 (0.5 mg protein) prior to incubation with chromium(VT) was 90% that of incubations consisting of chromium(VI) alone (Figure 1) . Although microsomes were almost as efficient as the S-105 fraction in their ability to decrease the mutagenicity of chromium(VI), addition ofdicumarol to microsomes showed little or no increase in the number of revertants per plate (Figure 1 ). Dicumarol also did not have a significant effect on the number CrfVI) + liver homogenate Cr(VI) + liver S12
CrfVI) + liver S105
Cr(VI) + liver microsomes Fig. 1 . Effect of dicumarol on the ability of rat liver subcellular fractions, tested at equivalent protein concentration, to affect the mutagenicity of chromium(Vr). Reactions were carried out as described earlier by De Flora a al. (9, 14) . Incubations were carried out at 37°C for 30 min after addition of 35 jig sodium dichromate [CrfVT)] to a preincubation mixture (10 min) of rat liver fraction, NADPH-generating system or control (lacking cell preparations and/or cofactors), in the presence or absence of 50 iM dicumarol or its control solution (0.01 N NaOH). The incubation mixtures were assayed at the end of 30 min in the Ames Salmonella plate incorporation test, using the TA100 tester strain. Results are the mean ± SD of triplicate plates.
of naturally occurring revertants in the TA100 Salmonella strain, or on the number of chromium(VT)-induced revertants (Figure 1) . The recovery of chromium(VI) mutagenicity in the presence of dicumarol, a DT-diaphorase inhibitor, suggests that the cytosolic enzyme DT-diaphorase may play a role in modulating the mutagenicity of chromium(VI).
Metabolism of chromium(VI) to chromiumfV) in the presence of rat liver cytosolic (S-105) fraction:
EPR spectroscopic studies at 297 K Reaction of chromium(Vr) (1.0 mM, 0.5 mM NajCrzO^fyO) with the NADPH-generating system in the presence of the S-105 fraction (1.0 mg protein/ml) was monitored by EPR spectroscopy at 297 K. cytosolic fraction for 30 min gave rise to a strong chromium(V) EPR signal with g av = 1.981 (AH = 2.2 G). Under indentical conditions, reaction of chromium(VI) with S-105 alone, NADPHgenerating system alone or NADPH (4.0 mM) alone produced similar but at least 10-fold less intense chromium(V) EPR signals than that obtained in the reaction of chromium(VT), S-105 and the NADPH-generating system (Figure 2b-d) . Reaction of chromium(VI) with the NADPH-generating system in the presence of purified DT-diaphorase (40 IU/ml; Figure 2e ) led to no increase in chromium(V) production over that obtained in the control incubations (Figure 2b-d) , although the activity of DT-diaphorase used in the reaction was almost 10 times higher than in the S-105 fraction. These results showed that the S-105 cytosolic fraction contained NADPH-dependent chromium(VI) reductase activity, which resulted in the production of chromium(V) species.
In order to ascertain the nature of the chromium(V) species formed in the cytosolic (S-105)-mediated reduction of chromium(VI) by NADPH, the reaction was studied under EPR spectral conditions of higher resolution (0.1 G modulation amplitude), and the resulting EPR spectrum was compared to EPR spectra characteristic of chromium(V) -NADH, chromium(V)-NADPH and chromium(V)-G6P complexes. Reaction of chromium(VI) (5.0 mM, 2.5 mM Na 2 Cr 2 O7• 2H 2 O) with 20.0 mM NADH at 297 K for 30 min, resulted in an EPR spectrum representative of the chromium(V)-NADH complex with g av = 1.981 and superhyperfine splitting of 0.81 G (Figure 3a) . A similar signal having g av = 1.981 and superhyperfine splitting constant 0.82 G was obtained for the chromium(V)-NADPH complex formed by the reaction of the chromium(VT) with NADPH ( Figure 3b ). Under similar conditions the reaction of chromium(VT) with G6P was very slow and the intensity of the chromium(V)-G6P EPR signal was very low. Therefore, the reaction was carried out at a relatively high Reactions were carried out as described in Materials and methods. EPR spectra were obtained 1 min after initiation of reactions by addition of chromium(VT), except for the reaction of chromium(VT) with G6P, which was recorded 6 h after initiation of reaction, and represent an average of 90 scans (21 s/scan). The spectra were recorded as described in Figure 2 , with 0.1 G modulation amplitude, 1.6 x 10 3 gain and 35 G sweep width.
concentration of chromium(Vi) (60.0 mM, 30.0 mM Na 2 Cr 2 Cy2H 2 O) and G6P (300 mM) and was allowed to proceed for 6 h before recording the EPR spectrum at 297 K for 30 min (Figure 3c ). The EPR spectrum of the chromium(V) -G6P complex was different from the EPR spectra of the chromium(V)-NADH and chromium(V)-NADPH complexes, but showed similar g value (g, v = 1.980) and superhyperfine splitting (0.84 G) features. The EPR spectra obtained for the NADH-, NADPH-and G6P-chromium(V) complexes are characteristic of Ws(diol)oxochromium(V) complexes in which the ligands have adjacent hydroxyl groups on a hydrocarbon ring skeleton (24, (32) (33) (34) (35) (36) . It should be noted that the ligand protons may be inequivalent (34) , and the superhyperfine splitting measured may represent the overlap of more than one splitting constant. In addition, the hydroxyl groups co-ordinated to chromium(V) may be protonated, and the protons may contribute to the superhyperfine splitting. Chromium(VI) (1.0 mM, 0.5 mM Na 2 Cr 2 Oy2H 2 O) was then incubated with the NADPHgenerating system in the presence of the S-105 fraction (1.0 mg/ml), and the reaction was monitored by EPR spectroscopy at 297 K. The chromium(V) EPR signal obtained upon reaction of chromium(VI) with the NADPH-generating system in the presence of the S-105 fraction (Figure 3d ) was characteristic of Wj(diol)oxochrorniurn(V) complexes (g av = 1.981, 0.83 G hyperfine splitting); however, the EPR spectrum resembled a composite of the chromium(V)-NADPH and the chro-
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Fig. 4. Comparative EPR study of chromium(V) complexes formed upon chromium{VI) metabolism by microsomes versus cytosol (S-105).
Chromium(VI) (1.0 mM, 0.5 mM Na^O; • 2H 2 O) was added to incubations of (a) microsomes (1.0 mg/ml protein) and 4.0 mM NADH, (b) microsomes (1.0 mg/ml protein) and NADPH, (c) same as (a) but with S-105 (1.0 mg/ml protein) instead of microsomes, (d) same as (b), but with S-105 (1.0 mg/ml protein) instead of microsomes. Reactions were initiated by addition of chromium(Vr). EPR spectra were recorded beginning 1 min from the start of each reaction, and represent an average of 90 scans (21 s/scan). The conditions are as described in Figure 3 . All spectra were recorded at 1.6 x 10 3 gain, but (a) and (b) were recorded at a 2-fold higher scale than (c) and (d). (Figure 3e ). These results suggest that the chromium(V) generated by chromium(VI) reductase activity in the S-105 cytosolic fraction forms stable complexes by co-ordination to NADPH and to G6P which was present in the NADPH-generating system.
mium(V)-G6P signals
Metabolism of chromium (VI) to chromium(V) in the presence of rat liver microsomal fraction: EPR spectroscopic studies at 297 K
Chromium(VI) reductase activity in the microsomes was studied by examining EPR-detectable chromium(V) species. Reaction of chromium(VI) (1.0 mM, 0.5 mM Na 2 Cr 2 O7 • 2H 2 O) with NADH (4.0 mM; Figure 4a ) or NADPH (4.0 mM; Figure 4b ) in the presence of microsomes (1.0 mg/ml) gave chromium(V) EPR signals similar to the chromium(V)-NADH or chromium(V) -NADPH complexes shown in Figure 3 . Under identical conditions, substituting the S-105 fraction (1.0 mg/ml) for the microsomal fraction led to detection of similar but 2-fold less intense chromium(V) EPR signals (Figure 4c-d) . For both the S-105 and microsomal fraction, NADH and NADPH were equally efficient electron donors to chromium(VI), giving rise to chromium(V) signals with similar intensities. These results suggest that enzymatic reduction of chromium(VI) by the microsomes leads to generation of a greater amount of chromium(V) than that obtained upon enzymatic reduction of chromium(VI) by the cytosolic (S-105) fraction. Both NADH and NADPH serve as electron donors for enzymes mediating chromium(VI) metabolism in the S-105 and microsomal fractions. Reactions were carried out using either S-105 or microsomal fractions (1.0 mg/ml protein) in the presence of a NADPH-generating system as described in Materials and methods. For reactions containing the microsomal fraction, the NADPH-generating system was supplemented with yeast G6PD (8 IU/ml). (Left to right): S-105, (S-105 + NADPH-generating system) + chromium(VT) (1.0 mM, 0.5 mM Na 2 Cr 2 Cy2H 2 O); S-105 + DC, (S-105 + NADPH-generating system + 50 jiM dicumarol) + chromium(VT); S-105 + KC, (S-105 + NADPH-generating system + 50 /iM ketoconazole) + chromiumCVT); Micr, (microsomes + NADPH-generating system + G6PD) + chromium(Vr); Micr + DC, (microsomes + NADPHgenerating system + G6PD + 50 fiM dicumarol) + chromium(VT); Micr + KC, (microsomes + NADPH-generating system + G6PD + 50 /iM ketoconazole) + chromium(VI). Components in parentheses were incubated for 10 min prior to addition of chromium(Vl). Reactions were initiated by the addition of chromium(VT) and EPR spectra recorded beginning 1 min from the start of the reaction. Conditions for recording the EPR spectra are as described in Figure 3 . Spectra represent an average of 90 scans (21 s/scan). Results are the mean ± SD of two determinations.
Effect of inhibitors of DT-diaphorase and MC-inducible cytochrome P450 on chromiumfV) production mediated by S-105 and microsomal fractions
Treatment of either S-105 or microsomal fractions with dicumarol (50 fiM) prior to addition of the NADPH-generating system (supplemented by 8 IU/ml G6PD in the case of microsomes) and chromium(VI) resulted in a 20-22% decrease in chromium(V) intensity in the S-105 fraction, and ~9% in the microsomal fraction ( Figure 5 ). In contrast, DT-diaphorase activity in the S-105 fraction was inhibited 90% by dicumarol under these conditions. Dicumarol (400 /tM) itself did not react with chromium(VT) (40 /tM). Purified rat liver DT-diaphorase showed no detectable NADH oxidase activity with chromium(VI) as a substrate, although DCPIP proved to be a very good substrate for DT-diaphorase (Table II) . Purified rat liver DT-diaphorase also showed no detectable NADPH-dependent chromium(VI) reductase activity (Table II) . Thus, DT-diaphorase appears to be only partially involved in the formation of chromium(V) species upon cytosolic metabolism of chromium(VI).
The S-105 and microsomal fractions were tested for inhibition of chromium(V) production by ketoconazole, which is an inhibitor of MC-inducible cytochrome P450 and cytochrome P450 3A enzymes. Ketoconazole (50 /xM) inhibited the AHH activity in the microsomal fraction by 69% and in the S-105 fraction by 63%, although the level of AHH activity in the S-105 fraction was very low. S-105 and microsomal fractions incubated with ketoconazole (50 /tM) and the NADPH-generating system, followed by addition of chromium(VI), showed a 10% decrease in chromium(V) EPR signal intensity ( Figure 5) . Thus, the MCinducible and other ketoconazole-inhibitable cytochrome P450 enzymes also appear to be only partly responsible for chromium(V) production in rat liver cytosolic and microsomal fractions.
Discussion
The results obtained in this study suggest that the metabolism of chromium(VT) in the cell involves a complex interplay of enzymatic and non-enzymatic intracellular components that may be involved in the reduction of chrornium(VT), and the formation and stabilization of chromium(V) complexes. Reaction of chromium(VI) and NADH or NADPH in the presence of either the cytosolic (S-105) or microsomal fractions resulted in the formation of chromium(V) species which resembled the chromium(V) complexes obtained upon reaction of chromium(VT) with NADH or NADPH alone. However, formation of chromium(V) was facilitated by addition of the subcellular fractions, since the EPR signals obtained upon reaction of chromium(VI) under identical conditions with NADH or NADPH alone were much less intense than those obtained in the presence of the rat liver cytosolic or microsomal fraction. Thus, both the microsomal and S-105 cytosolic fractions contain significant chromium(VT) reductase activity and produce chromium(V) complexes in the presence of pyridine nucleotide cofactors.
When chromium(VT) was incubated with the S-105 fraction in the presence of the NADPH-generating system instead of NADPH alone, the chromium(V) signal obtained appeared to be a composite of chromium(V)-NADPH and chromium(V)-G6P EPR signals. Thus, both the G6P and the NADP + or NADPH resulting from the reaction of NADP + with G6P may be involved in co-ordination to chromium(V). The results show that chromium(VI) reductase activities in both the S-105 and microsomal fractions facilitate one-electron transfer to chromium(VT), leading to formation of chromium(V) complexes with pyridine nucleotides and sugars as ligands. Jennette (11) has obtained evidence for the formation of two chromium(V) species upon incubation of rat liver microsomes with NADPH and chromium(VT): a major species with an EPR signal at g = 1.979, and a minor species with a slightly higher g value, whose EPR signal appeared as a shoulder to the main feature at g = 1.979. Shi et al. (37) found that reaction of NADPH with chromium(VT) in the presence of rat liver microsomes resulted in an EPR signal (g = 1.9792) characteristic of a chromium(V)-NADPH complex. The chromium(V) complexes with pyridine nucleotides and sugars are similar to those detected upon reaction of chromium(VT) with diols such as ethylene glycol and propylene glycol (22) (23) (24) . These chromium(V) complexes, which are normally very slow to form due to poor reactivity of 1164 diols with chromium(VI), are highly stable and long-lived due to diol co-ordination to chromium(V) through 5-membered ring chelates (36) . Thus, the formation of these chromium(V) complexes is facilitated through other enzymatic, and possibly non-enzymatic pathways in the cell which results in the transfer of one electron to chromium(VI). Once the chromium(V) center is formed, it can undergo rapid co-ordination to nucleotides, sugars and other diols which are present in the cell. Our studies showed that the post-mitochondrial fractions contained the bulk of the liver activity responsible for decreasing chromium(VI) mutagenicity in Salmonella TA100. It is possible that the chromium(V) complexes formed upon cytosolic and microsomal metabolism of cnromium(VT) are mutagenic. Farrell et al. (19) found that two chromium(V) complexes, bis(2-ethyl-2-hydroxybutanoato)chromium(V) and fc«(2-hydroxy-2-methylbutanoato)chromium(V), were as potent mutagens as chromium(VT) in the Ames Salmonella TA100 reversion assay. Reactive mutagenic species other than chromium(V) may also be generated as a result of chromium(VT) reductase activity and chromium(V) formation in the rat liver subcellular fractions. Although fc«(diol)oxochromium(V) complexes are normally stable, they may react with certain cellular components and cause damage in the cell. Reaction of chromium(VI) with NADPH resulted in the production of hydroxyl radical both in the presence and absence of microsomes, and addition of hydrogen peroxide to the chromium(V)-NADPH complex resulted in increased generation of hydroxyl radical (13, 37) . Shi et al. (37) observed that under anaerobic conditions the level of hydroxyl radical generated upon reaction of chromium(VI) with NADPH in the presence of microsomes was decreased. Sugden et al. (39) found that the ability of chromium(VT) to revert Salmonella strain 102 was strongly dependent on the presence of oxygen, and suggested that oxygen radicals may play a role in chromium(VT)-mediated bacterial mutagenicity.
Our studies have shown that DT-diaphorase in the cytosolic (S-105) fraction is only partially involved in chromium(V) production, since the chromium(V) signal intensity showed only a 20-22% decrease in the presence of dicumarol, conditions where DT-diaphorase activity was inhibited by 90%. In addition, purified DT-diaphorase did not catalyze reduction of chromium(VT) or formation of chromium(V). Earlier studies showed that, although failing to catalyze NADPH oxidation in the presence of chromium(VI), purified DT-diaphorase decreased chromium(VT) mutagenicity in the presence of NADH, and this effect was reversed by dkumarol (14) . These results with purified DT-diaphorase suggest that DT-diaphorase is involved in other redox processes in the cytosol which contribute to chromium(VI) metabolism and chromium(V) formation. It is possible that the effect of dicumarol on chromium(VI) mutagenicity in the Salmonella assay is related to DT-diaphorase catalyzed reactions involving oxygen radicals or other radical species. The possibility that dicumarol may inhibit the cytosol-mediated decrease in chromium(Vi) mutagenicity through pathways other than those involving DT-diaphorase inhibition must also be considered. Dicumarol is a very efficient inhibitor of DT-diaphorase (90 -95 % inhibition at a dicumarol concentration of 50 /iM), but it has also been shown to inhibit beef adrenal mitochondrial cytochrome P45O and hamster renal cortex cytochrome P450 (40, 41) . Dicumarol itself did not react with chromium(VT) and is unlikely to be directly responsible for chromiurn(VI) reductase activity. Shi and Dalai (8, 13) have observed that in the presence of NADPH, the cytosolic enzyme glutathione reductase catalyzes the reduction of chromium(VI) to chromium(V) species. Thus, it is possible that upon addition of NADPH to the cytosol, glutathione reductase catalyzes the reduction of chromium(VI) and leads to the detection of chromium(V) complexes.
Evidence for more than one metabolic pathway leading to chromium(VT)-induced genotoxicity has been obtained by Cupo and Wetterhahn (42) in chicken embryo hepatocytes. They found that induction of cytochrome P450 under conditions in which the glutathione content of the cells had been depleted led to little chromium(VI)-induced DNA strand breakage; however, induction of cytochrome P450 in cells having elevated levels of glutathione led to a greater amount of DNA strand breakage than that seen in the presence of elevated levels of glutathione alone (42) . The results obtained with the microsomal preparations show that MC-inducible cytochrome P450 activity is not involved to a great extent in the chromium(V) production detected in this study. This result is consistent with the observation of Petrilli et al. (26) that liver microsomes from rats which had been pretreated with MC had no increased activity compared to control microsomes in affecting chromium(Vi) mutagenicity. Studies by Mikalsen et al. (43) have shown that the highest V^^ for chromate reductase activity was found in microsomes from Aroclor-pretreated rats. Mikalsen et al. (44) , using reconstituted preparations of cytochrome P450 isoenzymes and NADPHcytochrome P450 reductase, found that rat P450HE1 was the most efficient isoenzyme in catalyzing chromium(VI) reduction; however, rat P450IIB1 and P450IA1, as well as the NADPHcytochrome P450 reductase also catalyzed chromium(VT) reduction. It should be noted that Aroclor 1254 is a potent inducer not only by cytochrome P450 but also of cytosolic enzymes such as G6PD, 6-phosphogluconate dehydrogenase, glutathione reductase and DT-diaphorase (9, 45) . Thus, it appears from our studies that cytochrome P450, like DT-diaphorase, may be either indirectly or only partially involved in chromium(Vi) metabolism in the cell. Our study also showed that the chromium(V) signal intensity was only slightly reduced when NADH was used instead of NADPH in the microsome-catalyzed reduction of chromium(VT), suggesting that NADH and NADPH-dependent chromium(VT)-reductase activities may both be important in the microsomal reduction of chromium(VI).
The role of non-enzymatic cellular components such as glutathione and ascorbate in the metabolic electron transfer to chromium(VI) has not been addressed in this study. The level of glutathione in all the subcellullar fractions (Table I) was too low for significant reaction to occur with the relative high chromium(VT) concentration (1.0 mM) used in our study. The rate of reduction of chromium(VI) by glutathione has been shown to be highly dependent on the glutathione concentration (46) . Chromium(V)-glutathione complex formation has been observed in reactions of chromium(Vi) with glutathione (18, 20, 21) , and these complexes have characteristic g values of 1.9% (AH = 4.0 G) and 1.986 (AH = 1.2 G). No evidence of chromium(V)-glutathione complex formation was obtained in the present study, where chromium(V) complexes with g values of 1.980-1.981 were observed.
The present study suggests that metabolic reduction of chromium(VT) involves a number of pathways, each of which may play a very different role with regard to chromium(VT) reduction. The results suggest that although DT-diaphorase may play a role in reverting the mutagenicity of chromium(VT) in bacterial assays, and to a small extent in the generation of chromium(V), its action requires the presence of other components in the cytosol, and may be mediated through reaction with radical species other than chromium(V). Although the mechanism of chromium(Vr) metabolism in the cells is complex, it is clear that the formation of chromhim(V) complexes stabilized by ligation to sugars and NAD(P)H can occur through more than one metabolic pathway.
